T.C. MİNİSTRY OF HEALTH İZMİR PROVINCIAL HEALTH DIRECTORATE S.B.Ü. DR.BEHÇET UZ CHİLDREN'S EDUCATİON AND RESEARCH HOSPİTAL
T.C. MİNİSTRY OF HEALTH İZMİR PROVINCIAL HEALTH DIRECTORATE S.B.Ü. DR.BEHÇET UZ CHİLDREN'S EDUCATİON AND RESEARCH HOSPİTAL

Facebook Twitter Google Plus Linkedin

Tuba Hilkay Karapınar, M.D.

Updated: 01/02/2019

A-PERSONAL INFORMATION

-Name -Surname : Tuba Hilkay KARAPINAR

-Birth date: 1969

-Forein language: English    

-Company: Dr. Behçet Uz Children’s Hospital, Department of Pediatric Hematology-Oncology.

B-EDUCATION INFORNATION

-Faculty: Istanbul University, Istanbul Medical Faculty

-Date of graduation: 1992

-Current duty: Pediatric Hematologist

-Title: Assoc. Prof. Dr.

C-WORK EXPERIENCE

-TC Ministry of Health Istanbul Şişli Etfal Research and Training Hospital

-TC Ministry of Health Dr. Behçet Uz Children’s Hospital

-TC Ministry of Health Izmir Atatürk Research and Training Hospital

-Dokuz Eylül University, Dokuz Eylül Medical Faculty  

-TC Ministry of Health Dr. Behçet Uz Children’s Hospital

D- CLINICAL RESEARCHS

1- Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia. Aydin Koker S, Karapinar TH, Oymak Y, Bianchi P, Fermo E, Gozmen S, Vergin C. J Pediatr  Hematol Oncol. 2018 Oct;40(7):e421-e423.

2- Evaluation of the Clinical and Laboratory Characteristics of Previously Followed-up Thalassemia Intermedia Patients to Provide Them Better Care in theFuture. Tüfekçi Ö, Atabay B, Türker M, Yilmaz Bengoa Ş, Gözmen S, Karapinar T, Ören H,İrken G (2017). J Pediatr Hematol Oncol. 39(6):440-444.

3-Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of 65 Patients.Tüfekçi Ö, Koçak Ü, Kaya Z, Yenicesu İ, Albayrak C, Albayrak D, Yılmaz Bengoa Ş, Patıroğlu T, Karakükçü M, Ünal E, Ünal İnce E, İleri T, Ertem M, Celkan T, Özdemir GN, Sarper N, Kaçar D, Yaralı N, Özbek NY, Küpesiz A, Karapınar T, VerginC, Çalışkan Ü, Tokgöz H, Sezgin Evim M, Baytan B, Güneş AM, Yılmaz Karapınar D,Karaman S, Uygun V, Karasu G, Yeşilipek MA, Koç A, Erduran E, Atabay B, Öniz H, Ören H (2017). Turk J Haematol. Feb 9.

4- HAX1 mutation positive children presenting with haemophagocytic lymphohistiocytosis.  Karapınar TH, Yılmaz Karapinar D, Oymak Y, Ay Y, Demirağ B, Aykut A, Onay H, Hazan F, Aydınok Y, Özkınay F, Vergin C (2017). Br J Haematol.  177 (4): 597-600.

5- Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis. Düzgöl M, Özek G, Bayram N, Oymak Y, Kara A, Demirağ B, Karapınar TH, Ay Y, Vergin C, Devrim İ (2016). Turk J Haematol. 33(4):346-348.

6- Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura. Ay Y, Karapınar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker S, Vergin C (2016). Blood Coagul Fibrinolysis. 27(4):431-5.

7- Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy. Tüfekçi Ö, Bengoa Yılmaz  Ş, Yenigürbüz   Demir F, Simsek E, Karapınar TH, Irken G, Ören H (2014). Turkish Journal of Hematology,

8- The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş A, Ören H, Baytan B, Bengoa Yılmaz Ş, Evim Sezgin M, Gözmen S, Tüfekçi Ö, Karapınar TH, İrken G (2014). Annals of Hematology, 93(10), 1677-1684. 
9-The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients. Karapınar TH, Karadaş N, Özek G, Tüfekçi Ö, Atabay B, Türker M, Yüksel F, Karapınar Yılmaz D, Vergin C, İrken G, Ören H (2014). Blood Coagulation&Fibrinolysis, 25(7), 703-708.
10- Multicentric plasma cell type of castleman disease in a child: difficulty in diagnosis and treatment. Karapınar TH, Tüfekçi Ö, Gözmen S, Yılmaz Ş, İrken G, Ören H (2013). Journal of Pediatric Hematology/Oncology, 35(7), 306-308.